Skip to Main Content
Pickering Laboratories Logo
Menu
         [zenlogin_prompt type=in_header]Online Shopping Cart icon Shop Online  |View Cart   Log Out[/zenlogin_prompt]
 
Menu

Library

Method Abstract 334

MA 334 / ANALYSIS OF ALPROSTADIL
BY HPLC WITH POST-COLUMN DERIVATIZATION

 
Alprostadil (Prostaglandin E1) is a drug that has vasodilation properties and is used to treat erectile dysfunction (ED) and other medical conditions. This medication is available in injectable form and in suppository form.

Since Prostaglandin E1 has low UV absorbance, the analysis of the formulations could be difficult. The addition of post-column derivatization increases the sensitivity and specificity of the analysis.

METHOD

Analytical Conditions

Analytical Column: Reversed-phase C18 column (150 x 4.6 mm)
Temperature: 37 °C
Flow Rate: 1 mL/min
Mobile Phase: 30% Acetonitrile – 70% of 0.02 M Potassium Phosphate monobasic (adjusted to pH 3) 

Or alternative conditions:

Mobile Phase: 25% Acetonitrile – 75% of 0.0067 M Potassium Phosphate buffer pH 6.3
Injection Volume: 20 uL

Post-column Conditions

Post-Column System: Pinnacle PCX
Reactor Volume: 2 mL
Reactor Temperature: 60 °C
Reagent: 1 mol/L Potassium Hydroxide
Reagent Flow Rate: 1 mL/min
Detection: UV 278 nm

Calibration

Alprostadil: 0.1 ug/mL – 10 ug/mL β-Naphthol (Internal Standard): 0.25 ug/mL – 10 ug/mL Make stock solutions of Alprostadil and β-Naphthol in anhydrous Ethanol. Prepare working standards by appropriate dilution of stock solution with mobile phase.

334a 334b 334c